Metabolic imaging of the human heart: Clinical application of magnetic resonance spectroscopy

Heart

Volumn 100, Issue 11, 2014, Pages 881-890

  Bizino, Maurice B ^a   Hammer, Sebastiaan ^a   Lamb, Hildo J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CARBON 13; CREATINE PHOSPHATE; PHOSPHORUS 31; PROTON; SODIUM 23;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CARDIAC IMAGING; CONGESTIVE CARDIOMYOPATHY; ENERGY METABOLISM; HEART FAILURE; HEART MUSCLE METABOLISM; HEART TRANSPLANTATION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; ISCHEMIC HEART DISEASE; METABOLIC SYNDROME X; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SODIUM NUCLEAR MAGNETIC RESONANCE; VALVULAR HEART DISEASE;

HEART FAILURE; MYOCARDIAL ISCHAEMIA AND INFARCTION (IHD);

ADENOSINE TRIPHOSPHATE; ENERGY METABOLISM; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MYOCARDIUM; REPRODUCIBILITY OF RESULTS;

EID: 84900298825     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2012-302546     Document Type: Article

References (20)

1. Neubauer S. The failing heart-an engine out of fuel. N Engl J Med 2007;356:1140-51.
2. Rijzewijk LJ, van der Meer RW, Smit JW, et al. Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus. J Am Coll Cardiol 2008;52: 1793-9.
3. Weiss RG, Bottomley PA, Hardy CJ, et al. Regional myocardial metabolism of high-energy phosphates during isometric exercise in patients with coronary artery disease. N Engl J Med 1990;323:1593-600.
4. Buchthal SD, den Hollander JA, Merz CN, et al. Abnormal myocardial phosphorus-31 nuclear magnetic resonance spectroscopy in women with chest pain but normal coronary angiograms. N Engl J Med 2000;342:829-35.
5. Johnson BD, Shaw LJ, Buchthal SD, et al. Prognosis in women with myocardial ischemia in the absence of obstructive coronary disease: results from the National Institutes of Health-National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE). Circulation 2004;109: 2993-9.
6. Yabe T, Mitsunami K, Inubushi T, et al. Quantitative measurements of cardiac phosphorus metabolites in coronary artery disease by 31P magnetic resonance spectroscopy. Circulation 1995;92:15-23.
7. Sandstede JJ, Pabst T, Beer M, et al. Assessment of myocardial infarction in humans with (23)Na MR imaging: Comparison with cine MR imaging and delayed contrast enhancement. Radiology 2001;221:222-8.
8. Golman K, Petersson JS, Magnusson P, et al. Cardiac metabolism measured noninvasively by hyperpolarized 13C MRI. Magn Reson Med 2008;59:1005-13.
9. Smith CS, Bottomley PA, Schulman SP, et al. Altered creatine kinase adenosine triphosphate kinetics in failing hypertrophied human myocardium. Circulation 2006;114:1151-8.
10. Lopaschuk GD, Folmes CD, Stanley WC. Cardiac energy metabolism in obesity. Circ Res 2007;101:335-47.
11. Fragasso G, Perseghin G, De CF, et al. Effects of metabolic modulation by trimetazidine on left ventricular function and phosphocreatine/adenosine triphosphate ratio in patients with heart failure. Eur Heart J 2006;27:942-8.
12. Neubauer S, Horn M, Cramer M, et al. Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy. Circulation 1997;96:2190-6.
13. Neubauer S, Krahe T, Schindler R, et al. 31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease. Altered cardiac high-energy phosphate metabolism in heart failure. Circulation 1992;86:1810-18.
14. Lamb HJ, Beyerbacht HP, van der Laarse A, et al. Diastolic dysfunction in hypertensive heart disease is associated with altered myocardial metabolism. Circulation 1999;99:2261-7.
15. Jung WI, Sieverding L, Breuer J, et al. 31P NMR spectroscopy detects metabolic abnormalities in asymptomatic patients with hypertrophic cardiomyopathy. Circulation 1998;97:2536-42.
16. Pluim BM, Lamb HJ, Kayser HW, et al. Functional and metabolic evaluation of the athlete's heart by magnetic resonance imaging and dobutamine stress magnetic resonance spectroscopy. Circulation 1998;97:666-72.
17. Abozguia K, Elliott P, McKenna W, et al. Metabolic modulator perhexiline corrects energy deficiency and improves exercise capacity in symptomatic hypertrophic cardiomyopathy. Circulation 2010;122:1562-9.
18. van der Meer RW, Lamb HJ, Smit JW, et al. MR imaging evaluation of cardiovascular risk in metabolic syndrome. Radiology 2012;264:21-37.
19. Hammer S, Snel M, Lamb HJ, et al. Prolonged caloric restriction in obese patients with type 2 diabetes mellitus decreases myocardial triglyceride content and improves myocardial function. J Am Coll Cardiol 2008;52:1006-12.
20. Schroeder MA, Clarke K, Neubauer S, et al. Hyperpolarized magnetic resonance: A novel technique for the in vivo assessment of cardiovascular disease. Circulation 2011;124:1580-94.